Trinity Biotech Plc (TRIB)
1.16
-0.04
(-3.33%)
USD |
NASDAQ |
Dec 10, 11:09
Trinity Biotech Shareholders Equity (Quarterly): -43.62M for March 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| DBV Technologies SA | 52.85M |
| Cellectis SA | 100.48M |
| Akari Therapeutics Plc | 22.69M |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | 34.90M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 99.79M |
| Total Liabilities (Quarterly) | 143.41M |
| Debt to Equity Ratio | -2.475 |
| Current Ratio | 1.166 |
| Net Debt Paydown Yield | -76.35% |